ID   NW38
AC   CVCL_S591
SY   NW-38; NW-MEL-38
DR   Wikidata; Q54931194
RX   PubMed=9432985;
RX   PubMed=12747757;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
RX   PubMed=9432985; DOI=10.1084/jem.187.2.265; PMCID=PMC2212106;
RA   Jager E., Chen Y.-T., Drijfhout J.W., Karbach J., Ringhoffer M.,
RA   Jager D., Arand M., Wada H., Noguchi Y., Stockert E., Old L.J.,
RA   Knuth A.;
RT   "Simultaneous humoral and cellular immune response against cancer-testis
RT   antigen NY-ESO-1: definition of human histocompatibility leukocyte
RT   antigen (HLA)-A2-binding peptide epitopes.";
RL   J. Exp. Med. 187:265-270(1998).
//
RX   PubMed=12747757;
RA   Jager E., Karbach J., Gnjatic S., Jager D., Maeurer M.J., Atmaca A.,
RA   Arand M., Skipper J.C.A., Stockert E., Chen Y.-T., Old L.J., Knuth A.;
RT   "Identification of a naturally processed NY-ESO-1 peptide recognized
RT   by CD8+ T cells in the context of HLA-B51.";
RL   Cancer Immun. 2:12-12(2002).
//